MedTrace Logo

A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants

NCT01494714 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-10-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate skin irritation and photo irritation of JNJ 10229570-AAA on intact skin of Japanese healthy male participants.

Conditions

  • Healthy Volunteers

Interventions

DRUG

JNJ 10229570-AAA 1.2% cream

A patch containing the cream will be applied on the back and left for 48 hours on the left side, and 24 hours on the right side.

DRUG

JNJ 10229570-AAA 2.4% cream

A patch containing the cream will be applied on the back and left for 48 hours on the left side, and 24 hours on the right side.

DRUG

JNJ 10229570-AAA 3.6% cream

A patch containing the cream will be applied on the back and left for 48 hours on the left side, and 24 hours on the right side.

DRUG

Color-matched vehicle in a cream formulation containing 0 mg of JNJ 10229570-AAA

A patch containing the cream will be applied on the back and left for 48 hours on the left side, and 24 hours on the right side.

DRUG

Petroleum jelly

A patch containing the petroleum jelly will be applied on the back and left for 48 hours on the left side, and 24 hours on the right side.

Sponsors & Collaborators

  • Janssen Pharmaceutical K.K.

    lead INDUSTRY

Principal Investigators

  • Janssen Pharmaceutical K.K., Japan Clinical Trial · Janssen Pharmaceutical K.K.

Study Design

Allocation
NA
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01494714 on ClinicalTrials.gov